You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
2021-10-04
Oct 4, 2021
C
Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Lymphoma, Non-Hodgkin
  • New York, New York
  • +13 more
2021-08-26
Aug 26, 2021
D
Active, not recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Duarte, California
  • +5 more
2022-03-28
Mar 28, 2022
T
Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Pediatric Hodgkin Lymphoma
  • Brentuximab Vedotin (Genetical Recombination)
  • Tokyo, Japan
    Takeda Selected Site
2021-09-29
Sep 29, 2021
I
Recruiting
  • Non Hodgkins Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Aichi, Japan
  • +4 more
2022-01-24
Jan 24, 2022
K
Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Louisville, Kentucky
    Norton Cancer Institute
2022-03-01
Mar 1, 2022
O
Active, not recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
  • Yamagata, Japan
    Yamagata University Hospital
2022-02-21
Feb 21, 2022
S
Recruiting
  • DLBCL
  • R-DHAP
  • Brentuximab Vedotin
  • Rotterdam, Netherlands
    NL-Rotterdam-ERASMUSMC
2020-12-09
Dec 9, 2020
T
Recruiting
  • Peripheral T Cell Lymphoma
  • Relapse/Recurrence
  • Antwerpen, Belgium
  • +38 more
2021-12-06
Dec 6, 2021
S
Completed
  • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    2022-02-04
    Feb 4, 2022
    M
    Recruiting
    • Acute Lymphoblastic Leukemia Recurrent
    • +4 more
    • MB-CART19.1
    • Berlin, Germany
    • +9 more
    2021-11-30
    Nov 30, 2021
    A
    Recruiting
    • Relapsed/Refractory Peripheral T-cell Lymphoma
    • Relapsed/Refractory Classical Hodgkins Lymphoma
    • Duarte, California
    • +27 more
    2022-03-01
    Mar 1, 2022
    H
    Active, not recruiting
    • Peripheral T-Cell Lymphoma (PTCL)
    • Akita, Japan
    • +22 more
    2021-12-09
    Dec 9, 2021
    N
    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Diffuse Large B-cell Lymphoma
    • Tisagenlecleucel
    • Hamilton, Ontario, Canada
    • +33 more
    2022-01-28
    Jan 28, 2022
    U
    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • +5 more
    • CD19.CAR T Cells
    • +2 more
    • Heidelberg, Germany
    • +1 more
    2020-11-18
    Nov 18, 2020
    P
    Recruiting
    • Non-Hodgkin's Lymphoma, Relapsed
    • +8 more
    • PBCAR20A
    • +2 more
    • Duarte, California
    • +4 more
    2021-04-28
    Apr 28, 2021
    S
    Completed
    • Diffuse Large B-cell Lymphoma
    • CHOP and BFM regiments
    • (no location specified)
    2021-01-25
    Jan 25, 2021
    N
    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • Tisagenlecleucel
    • Los Angeles, California
    • +25 more
    2022-03-04
    Mar 4, 2022
    H
    Recruiting
    • B-cell Non-Hodgkin Lymphoma
    • Mosunetuzumab (IV)
    • +3 more
    • Birmingham, Alabama
    • +20 more
    2022-03-17
    Mar 17, 2022
    B
    Active, not recruiting
    • Hematoma
    • Beijing, China
      Beijing university cancer hospital
    2022-01-10
    Jan 10, 2022
    C
    Recruiting
    • Lymphoma, Non-Hodgkin
    • Minneapolis, Minnesota
    • +11 more
    2022-02-10
    Feb 10, 2022